VialIpamorelin 10 mg vial
Growth hormone release
Investigated for selective growth hormone release.
- Ships from Canada in 1–2 business days
- Free shipping over $120
Place your order, then send the e-Transfer. We pack it as soon as it arrives.
For research use only. Not for human consumption.
Complete your setup
Needles and wipes are free. Water is $19.
- Bacteriostatic Water
$19.00 · To reconstitute the powder
- Needles
Free · For reconstitution
- Alcohol Wipes
Free · To prep the vial stopper
Compare. Side by side, from the research.
About Ipamorelin
Ipamorelin is a selective growth-hormone secretagogue. Research examines it specifically for its selectivity, releasing growth hormone with minimal effect on cortisol or prolactin.
How it works
- Receptor Selectivity
- Studied for acting at the ghrelin receptor with minimal associated cortisol or prolactin response.
- Pulsatile Release
- Explored for producing a release pattern that resembles the body's own rhythm.
What you need
- Bacteriostatic Water
- Needles
- Alcohol Wipes
- A protocol guide comes with every order
Shipping & payment
- Packed and dispatched within 1–2 business days
- Delivered across Canada in 2–5 business days, tracked
- Temperature-controlled packaging where the product needs it
- Free shipping on orders over $120
- Prices in CAD · pay by Interac e-Transfer
- Format
- Lyophilised powder in a sealed vial
- Strength
- 10 mg per vial
- Storage
- Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
- Reconstitution
- 2 mL bacteriostatic water for this 10 mg vial (5 mg/mL)
- Route in research
- Subcutaneous
- Target
- GHS-R1a
- SKU
- IP10
Handling
- 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
- 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
- 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
- Purity
- High-performance liquid chromatography (HPLC), by an independent laboratory
- Identity
- Mass spectrometry, on the same batch
- How often
- Every batch
- COA
- The certificate of analysis is matched to the lot code printed on your vial
- Evidence
- Preclinical
Check your lot
Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.
PreclinicalThe primary studies on Ipamorelin are animal studies of growth hormone release and bone growth, while more recent reviews discuss it among unapproved peptides, so controlled human evidence is limited.
What research examines
- Selective growth hormone release
- Minimal cortisol and prolactin response
- Longitudinal bone growth in rats
- Body composition in reviews of GH secretagogues
- Musculoskeletal and sports medicine peptide research
Reported in studies
- Human safety data are limited
- Early research reported minimal effects on cortisol and prolactin
- Recent reviews assess it among unapproved peptide therapies
- Reviews discuss its use in sport and bodybuilding in a doping context
Published research protocols
300 mcg, 5 days on 2 days off, pm fasted
Research protocols have used 200–500 mcg per administration, 5 days per week (evening, fasted), in 8-week blocks with 4 weeks off.
For research use only. These figures summarize published research protocols. They are not instructions or medical advice.
Measure with the calculatorCoreX AI
Ask about Ipamorelin
Plain answers, from the basics to the studies.
Research information, not medical advice.
Often researched with Ipamorelin
Vial
Vial
Vial
FAQ
Questions, answered
Ipamorelin is a synthetic growth hormone secretagogue. A 1998 paper described it as the first selective compound of this type. Research has focused on its selectivity. It stimulates growth hormone release with minimal reported effect on cortisol or prolactin, which set it apart from earlier secretagogues with broader hormonal activity. It is sold for laboratory research use only.
Research describes Ipamorelin as an agonist at the ghrelin receptor, GHS-R1a. Activating this receptor has been studied as a way to stimulate growth hormone release from the pituitary. Research has also explored whether Ipamorelin produces a pulsatile release pattern that resembles the body's own growth hormone rhythm. Its selectivity for growth hormone over cortisol and prolactin is the feature most often examined.
Early studies examined its selective growth hormone releasing activity. A 1999 study in rats reported that it induced longitudinal bone growth. More recent reviews discuss Ipamorelin alongside other growth hormone secretagogues in body composition research, orthopaedic and sports medicine, and healthy aging. These reviews generally frame it as an investigational compound, and controlled human outcome data remain limited.
Human safety data for Ipamorelin are limited. Early research emphasized its minimal effect on cortisol and prolactin compared with earlier secretagogues. Recent reviews assess the safety and efficacy of unapproved peptide therapies, including compounds of this class. Other reviews examine its use in recreational and professional sport and bodybuilding in a doping context. Adverse events are not comprehensively summarized in the cited studies.
Research protocols have used 200–500 mcg per administration, 5 days per week, in the evening in a fasted state. These protocols ran in 8-week blocks followed by 4 weeks off, and the route described is subcutaneous. These figures describe research protocols only. Each CoreX order ships with a protocol guide for laboratory reference.
You may also like
Vial · Pen
Vial · Pen
Vial
Vial

